Stockreport

Maravai LifeSciences Holdings Inc (MRVI) Q3 2024 Earnings Call Highlights: Navigating ... [Yahoo! Finance]

Maravai LifeSciences Holdings, Inc. - Class A common stock  (MRVI) 
PDF Maravai LifeSciences Holdings Inc ( NASDAQ:MRVI ) reported $65 million in revenue for Q3 2024, with $50 million coming from the Nucleic Acid Production (NAP) segment. [Read more]